{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:12:35Z","timestamp":1792156355943,"version":"4.4.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Sleep Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.5664\/jcsm.9326","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T14:00:20Z","timestamp":1619186420000},"page":"1895-1945","source":"Crossref","is-referenced-by-count":84,"title":["Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment"],"prefix":"10.1007","volume":"17","author":[{"given":"Kiran","family":"Maski","sequence":"first","affiliation":[{"name":"Department of Neurology, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn Marie","family":"Trotti","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Kotagal","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Robert Auger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd J.","family":"Swick","sequence":"additional","affiliation":[{"name":"Neuroscience\u2019s Clinical Division, Takeda Pharmaceuticals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Rowley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Hashmi","sequence":"additional","affiliation":[{"name":"American Academy of Sleep Medicine, Darien, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel F.","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"e_1_3_3_2_2","article-title":"Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline","author":"Maski K, Trotti LM, Kotagal S, et\u00a0al","year":"2021","unstructured":"Maski K, Trotti LM, Kotagal S, et\u00a0al . Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline . J\u00a0Clin Sleep Med . 2021 ; 17(9):1881\u20131893.","journal-title":"J\u00a0Clin Sleep Med"},{"key":"e_1_3_3_3_2","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep\u00a0Disorders . 3rd ed. Darien, IL : American Academy of Sleep Medicine ; 2014 .","journal-title":"International Classification of Sleep\u00a0Disorders"},{"issue":"23","key":"e_1_3_3_4_2","first-page":"620","article-title":"The treatment of narcolepsy with methylphenylpiperidylacetate: a preliminary report","volume":"31","author":"Daly DD","year":"1956","unstructured":"Daly DD , Yoss RE . The treatment of narcolepsy with methylphenylpiperidylacetate: a preliminary report . Proc Staff Meet Mayo Clin . 1956 ; 31 ( 23 ): 620 \u2013 625 .","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"e_1_3_3_5_2","author":"American Academy of Sleep Medicine","year":"2001","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders: Diagnostic and Coding Manual . 1st ed-revised. Rochester, MN : American Academy of Sleep Medicine ; 2001 .","journal-title":"International Classification of Sleep Disorders: Diagnostic and Coding Manual"},{"key":"e_1_3_3_6_2","author":"American Academy of Sleep Medicine","year":"2005","unstructured":"American Academy of Sleep Medicine . International Classification of Sleep Disorders: Diagnostic and Coding Manual . 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005 .","journal-title":"International Classification of Sleep Disorders: Diagnostic and Coding Manual"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6494"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.05.037"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0866-y"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-016-0409-2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.12.1705"},{"issue":"4","key":"e_1_3_3_12_2","first-page":"451","article-title":"Practice parameters for the treatment of narcolepsy: an update for 2000","volume":"24","author":"Littner M","year":"2001","unstructured":"Littner M , Johnson SF , McCall WV , et\u00a0al .; Standards of Practice Committee . Practice parameters for the treatment of narcolepsy: an update for 2000 . Sleep . 2001 ; 24 ( 4 ): 451 \u2013 466 .","journal-title":"Sleep"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/17.4.348"},{"issue":"6","key":"e_1_3_3_14_2","first-page":"487","article-title":"Rules of evidence and clinical recommendations for the management of patients","volume":"9","author":"Sackett DL","year":"1993","unstructured":"Sackett DL . Rules of evidence and clinical recommendations for the management of patients . Can J Cardiol . 1993 ; 9 ( 6 ): 487 \u2013 489 .","journal-title":"Can J Cardiol"},{"key":"e_1_3_3_15_2","unstructured":"Eddy\nDM\n. A Manual for Assessing Health Practices & Designing Practice Policies: The Explicit Approach. Philadelphia PA: American College of Physicians; \n1992\n."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.12.1712"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.5412"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.02.003"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X100050"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27934"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.4196"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27935"},{"key":"e_1_3_3_26_2","unstructured":"U.S. National Library of Medicine\n. \nThe Nuvigil and Provigil Pregnancy Registry\n. \nhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT01792583\n. Accessed April 24 2020\n."},{"key":"e_1_3_3_27_2","unstructured":"Centers for Medicare & Medicaid Services. NADAC (National Average Drug Acquisition Cost). https:\/\/data.medicaid.gov\/Drug-Pricing-and-Payment\/NADAC-National-Average-Drug-Acquisition-Cost-\/a4y5-998d\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.1995.tb00159.x"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.36.6.1076"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.290.6476.1167"},{"key":"e_1_3_3_31_2","unstructured":"Dexedrine [prescribing information] (dextroamphetamine sulfate). Horsham PA: Amedra Pharmaceuticals LLC. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/017078s049lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053707"},{"issue":"5","key":"e_1_3_3_33_2","first-page":"362","article-title":"REM changes in narcolepsy with selegiline","volume":"18","author":"Reinish LW","year":"1995","unstructured":"Reinish LW , MacFarlane JG , Sandor P , Shapiro CM . REM changes in narcolepsy with selegiline . Sleep . 1995 ; 18 ( 5 ): 362 \u2013 367 .","journal-title":"Sleep"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/17.suppl_8.S103"},{"key":"e_1_3_3_35_2","unstructured":"Honda\nY Hishikawa Y Takahashi\nY\n. \nLong term treatment of narcolepsy with methylphenidate (Ritalin). Curr Ther Res . \n1979\n;\n25(2):288\u2013298."},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.03.060"},{"key":"e_1_3_3_37_2","unstructured":"Concerta [prescribing information] (methylphenidate). Titusville NJ: Janssen Pharmaceuticals Inc. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021121s038lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/17.suppl_8.S107"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.07.003"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.03.010"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.444"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70225-4"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(99)00014-3"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2008.12.005"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.7.939"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430115"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.5.1166"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1508-9"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1389-9457(00)00031-9"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1389-9457(02)00240-x"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1343-4"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200309000-00009"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/22.6.757"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.07.030"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0543-8"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10390"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/25.8.62"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e31815abefb"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0911"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fd62a2"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.065870"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181aa916a"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12201"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03223.x"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200203000-00010"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0318"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-199303000-00009"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30333-7"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2007.12.003"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.01.021"},{"key":"e_1_3_3_71_2","unstructured":"Wakix [prescribing information] (pitolisant)\n. \nPlymouth Meeting PA: Harmony Biosciences LLC. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211150s000lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.11.2095"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199508000-00002"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/13.6.479"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.26368"},{"issue":"1","key":"e_1_3_3_76_2","first-page":"42","article-title":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","year":"2002","unstructured":"A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy . Sleep . 2002 ; 25 ( 1 ): 42 \u2013 49 .","journal-title":"Sleep"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2005.03.010"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-016-0053-5"},{"issue":"1","key":"e_1_3_3_79_2","first-page":"31","article-title":"A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy","volume":"26","author":"U.S. Xyrem Multicenter Study Group","year":"2003","unstructured":"U.S. Xyrem Multicenter Study Group . A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy . Sleep . 2003 ; 26 ( 1 ): 31 \u2013 35 .","journal-title":"Sleep"},{"issue":"6","key":"e_1_3_3_80_2","first-page":"222","article-title":"The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy","volume":"46","author":"Scharf MB","year":"1985","unstructured":"Scharf MB , Brown D , Woods M , Brown L , Hirschowitz J . The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy . J\u00a0Clin Psychiatry . 1985 ; 46 ( 6 ): 222 \u2013 225 .","journal-title":"J\u00a0Clin Psychiatry"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12386"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.10.005"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1159\/000324549"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/27.7.1327"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2003.11.002"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/29.9.1189"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12468"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.3171"},{"key":"e_1_3_3_89_2","unstructured":"Xyrem [prescribing information] (sodium oxybate). Palo Alto CA: Jazz Pharmaceuticals Inc. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/021196s030lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12794"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2019.11.1250"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.05.013"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.5968"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25423"},{"key":"e_1_3_3_95_2","unstructured":"Sunosi [\ndrug approval package\n] (solriamfetol hydrochloride)\n. \nJazz Pharmaceuticals Ireland Limited. \nhttps:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2019\/211230Orig1Orig2s000TOC.cfm.Accessed\n May 4 2021\n."},{"key":"e_1_3_3_96_2","unstructured":"Sunosi [prescribing information] (solriamfetol). Palo Alto CA: Jazz Pharmaceuticals Inc. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211230s000lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/15.3.212"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24459"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113515062"},{"key":"e_1_3_3_100_2","unstructured":"U.S. Food & Drug Administration\n. \nFDA drug safety communication: FDA review finds additional data supports potential increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. \nhttps:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-review-finds-additional-data-supports-potential-increased-long\n. Accessed December 15 2019\n."},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6196"},{"key":"e_1_3_3_102_2","unstructured":"Romazicon [drug information] (flumazenil). Nutley NJ: Roche Laboratories Inc. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/020073s016lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27658"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/30.10.1274"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(88)90014-0"},{"key":"e_1_3_3_106_2","unstructured":"Provigil [prescribing information] (modafinil) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020717s037s038lbl.pdf\n. Accessed May 4 2021."},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002104"},{"key":"e_1_3_3_108_2","unstructured":"Lithium and lithium carbonate [prescribing information] (lithium). Columbus OH: Roxane Laboratories Inc. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/017812s027%2C018421s025%2C018558s021lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005349"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1159\/000471507"},{"key":"e_1_3_3_111_2","unstructured":"[prescribing information] (armodafinil). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021875s023lbl.pdf\n. Accessed May 4 2021\n."},{"key":"e_1_3_3_112_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.5192"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.08.007"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(03)00030-0"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(96)05328-2"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0765-6"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-015-0074-6"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00294-4"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104910.75206.b9"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1607-551X(10)70068-1"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/33.11.1457"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(18)30133-0"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy050"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.02.008"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.10.032"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6500"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.10.1553"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.3756"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813751"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature14035"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:16:28Z","timestamp":1770110188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.5664\/jcsm.9326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":129,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.5664\/jcsm.9326"],"URL":"https:\/\/doi.org\/10.5664\/jcsm.9326","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}